Value proposition

A fast-growing contract research organization (CRO) advancing the latest drug development in human & animal healthcare

With its presence in three locations across North America and Europe, KCAS Bio is a leading contract research organization (CRO) employing top scientific talent and providing comprehensive bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond.

The collaboration of the three entities allows for global support in bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. The KCAS family of companies operates in state-of-the-art facilities in the United States and Europe.

This business structure enables the expertise, capacity, and flexibility to support the development of all types of drugs, biologics, cell and gene therapies to improve health worldwide.

Our purpose is to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.

Immunogenicity (ADA), Flow Cytometry, Vaccines, Method Dev + Transfer, Clinical PK/PD Kits, LC-MS/MS, GLP, GCP, non-GLP, ECL - MSD, ELISA, Biopharma LC-MS/MS, Receptor Occupancy, Luminex, Biomarkers, PD Biomarkers, PK / TK, and Hybrid LC-MS/MS